Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Elliot H. Philipson, MD, is Chair of Obstetrics & Gynecology at Hillcrest Hospital. He is a Professor of Surgery for Cleveland Clinic Lerner College of Medicine, Department of Obstetrics and Gynecology. His previous appointments with Cleveland Clinic include Vice Chair of the Department of Obstetrics and Gynecology; Section Head of Obstetrics and Maternal-Fetal Medicine; Directory of Obstetrical Ultrasound; and Director of Obstetrical Quality Assurance.
Dr. Philipson is board certified in maternal-fetal medicine. He completed his undergraduate degree at University of Vermont and earned his medical degree from University of Rome Faculty of Medicine and Surgery. His post-graduate training includes an obstetrics and three-year gynecology residency at Albany Medical Center Hospital in Albany, N.Y., followed by a two-year maternal-fetal medicine fellowship at Cleveland Metropolitan General Hospital and Case Western Reserve University in Cleveland, Ohio. Dr. Philipson also completed an Executive Program in Practice Management with Cleveland Clinic and earned his MBA from Cleveland State University.
Dr. Philipson is a Diplomate of the American Board of Obstetrics & Gynecology Maternal-Fetal Medicine. In addition, he is on the Board of Governors of the Central Association of Obstetricians and Gynecologists.
Dr. Philipson has been recognized Castle Connolly in their guide to America’s Top Doctors for the past nine years; he has been recognized multiple years in a row in “Best Doctors in America” which is an on-line resource developed by Best Doctors Inc.; and he has been listed in Marquis Who’s Who in America. He also has received a number of teaching awards for outstanding teaching and excellence in resident education.
Dr. Philipson has received a number of research grants and has published multiple research articles in peer-reviewed journals, as well as having contributed abstracts and presentations at a number of professional association meetings. His current research focuses on quality assurance and improvement in obstetrics; obstetrical practice and management issues; the cost of healthcare; and group B streptococcus sensitivity and screening protocols, among others.
Amniocentesis, chronic villus sampling, diabetes in pregnancy, high risk pregnancies, maternal-fetal medicine, maternal-fetal medicine and ultrasonography, medical and obstetrical complications of pregnancy, ultrasound genetic counseling
Awards & Honors
America's Best Physicians, past 5 years
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 3/23/2013, Dr. Philipson has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.